{"id":79327,"date":"2026-04-29T13:10:03","date_gmt":"2026-04-29T07:40:03","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=79327"},"modified":"2026-04-29T13:27:08","modified_gmt":"2026-04-29T07:57:08","slug":"sanofi-india-q4-fy26-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/sanofi-india-q4-fy26-results\/","title":{"rendered":"Sanofi India Q4 FY26 Results PAT Growth as Prescription Pharma Portfolio Delivers"},"content":{"rendered":"<div class=\"meta-block\">\u00a0<\/div>\n<p>Sanofi India Q4 FY26 financial results are announced on April 28, 2026, posting a PAT of Rs 92 crore higher year-on-year, as the Pharmaceuticals company delivered its January to March 2026 quarter earnings. Investors seeking live stock data, expert analysis, and research on <strong>Sanofi India Q4 FY26 results<\/strong> can track the stock at <a href=\"https:\/\/univest.in\/user\/stocks\/sanofi\/sanofi-india-ltd-share-price-today\"><strong>Sanofi India on Univest<\/strong><\/a>.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-india-q4-fy26-results\/#Sanofi_India_Q4_FY26_Financial_Highlights\" title=\"Sanofi India Q4 FY26 Financial Highlights\">Sanofi India Q4 FY26 Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-india-q4-fy26-results\/#Sanofi_India_Q4_FY26_Performance_Analysis\" title=\"Sanofi India Q4 FY26 Performance Analysis\">Sanofi India Q4 FY26 Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-india-q4-fy26-results\/#Full_Year_FY26_Business_Summary\" title=\"Full Year FY26 Business Summary\">Full Year FY26 Business Summary<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-india-q4-fy26-results\/#Management_Outlook_and_FY27_Priorities\" title=\"Management Outlook and FY27 Priorities\">Management Outlook and FY27 Priorities<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-india-q4-fy26-results\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-india-q4-fy26-results\/#Frequently_Asked_Questions_FAQs\" title=\"Frequently Asked Questions FAQs\">Frequently Asked Questions FAQs<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-india-q4-fy26-results\/#What_was_Sanofi_India_Q4_FY26_PAT\" title=\"What was Sanofi India Q4 FY26 PAT?\">What was Sanofi India Q4 FY26 PAT?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-india-q4-fy26-results\/#What_was_Sanofi_India_revenue_in_Q4_FY26\" title=\"What was Sanofi India revenue in Q4 FY26?\">What was Sanofi India revenue in Q4 FY26?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-india-q4-fy26-results\/#Did_Sanofi_India_declare_a_dividend_for_FY26\" title=\"Did Sanofi India declare a dividend for FY26?\">Did Sanofi India declare a dividend for FY26?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-india-q4-fy26-results\/#How_did_Sanofi_India_perform_in_FY26_overall\" title=\"How did Sanofi India perform in FY26 overall?\">How did Sanofi India perform in FY26 overall?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-india-q4-fy26-results\/#What_is_the_outlook_for_Sanofi_India_in_FY27\" title=\"What is the outlook for Sanofi India in FY27?\">What is the outlook for Sanofi India in FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-india-q4-fy26-results\/#Where_can_I_track_Sanofi_India_stock_and_results\" title=\"Where can I track Sanofi India stock and results?\">Where can I track Sanofi India stock and results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-india-q4-fy26-results\/#What_sector_does_Sanofi_India_operate_in\" title=\"What sector does Sanofi India operate in?\">What sector does Sanofi India operate in?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-india-q4-fy26-results\/#Is_Sanofi_India_a_good_investment_after_Q4_FY26_results\" title=\"Is Sanofi India a good investment after Q4 FY26 results?\">Is Sanofi India a good investment after Q4 FY26 results?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/sanofi-india-q4-fy26-results\/#Recent_Article\" title=\"Recent Article\">Recent Article<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Sanofi_India_Q4_FY26_Financial_Highlights\"><\/span><strong>Sanofi India Q4 FY26 Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Sanofi India Limited Q4 FY26 financial results are out on April 28, 2026. The listed subsidiary of global pharma major Sanofi SA reported improved profitability driven by its prescription pharmaceutical portfolio including diabetes, cardiovascular, and specialty medicines.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Metric<\/th>\n<th>Q4 FY26<\/th>\n<th>Q4 FY25<\/th>\n<th>Change<\/th>\n<\/tr>\n<tr>\n<td>Revenue \/ Total Income<\/td>\n<td>approximately Rs 720 crore<\/td>\n<td>Refer NSE filing<\/td>\n<td>Grew (year-on-year growth)<\/td>\n<\/tr>\n<tr>\n<td>PAT<\/td>\n<td>Rs 92 crore<\/td>\n<td>Refer NSE filing<\/td>\n<td>Higher YoY<\/td>\n<\/tr>\n<tr>\n<td>Full Year FY26 PAT<\/td>\n<td>Refer annual filing<\/td>\n<td>Refer filing<\/td>\n<td>As reported<\/td>\n<\/tr>\n<tr>\n<td>Dividend<\/td>\n<td>Not declared<\/td>\n<td>Refer filing<\/td>\n<td>FY26 final<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Sanofi_India_Q4_FY26_Performance_Analysis\"><\/span><strong>Sanofi India Q4 FY26 Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Sanofi India&#8217;s prescription portfolio, including Lantus (insulin glargine) and cardiovascular brands, continued to generate steady revenue in Q4 FY26, benefiting from chronic disease management growth across India&#8217;s urban and semi-urban markets.<\/p>\n<p>The company&#8217;s operational efficiency and cost management focus contributed to margin improvement in Q4 FY26. Sanofi India has been a consistent dividend-paying company and maintains high standards of corporate governance as a multinational subsidiary.<\/p>\n<p><em>Also Read:\u00a0<a href=\"https:\/\/univest.in\/blogs-2\/bhansali-engineering-polymers-q4-fy26-results-pat-51-crore\/\">Bhansali Engineering Polymers Q4 FY26 Results<\/a><\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Full_Year_FY26_Business_Summary\"><\/span><strong>Full Year FY26 Business Summary<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>FY26 was a year of stable growth for Sanofi India, with the prescription pharma business benefiting from increasing diabetes and cardiovascular disease burden in India and growing physician and patient engagement programmes.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Management_Outlook_and_FY27_Priorities\"><\/span><strong>Management Outlook and FY27 Priorities<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Sanofi India Q4 FY27 growth will be driven by expanding access to its diabetes and specialty care portfolio. The global parent&#8217;s pipeline of specialty biologics, if approved for India, could significantly expand the India business in the medium term.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Sanofi India Q4 FY26 results<\/strong> reflect the company&#8217;s operational performance in the January to March 2026 quarter with PAT of Rs 92 crore. The Pharmaceuticals company&#8217;s results are an important input for investors tracking the earnings season. Investors should review the full exchange filing on NSE and BSE for complete audited financials before making any investment decisions.<\/p>\n<p><em>This article is for informational and educational purposes only. It is not investment advice. Please consult a SEBI registered investment advisor before making any investment decisions. Past performance is not indicative of future results.<\/em><\/p>\n<p>Get free investment predictions on\u00a0<a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Univest<\/strong><\/a>.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_FAQs\"><\/span><strong>Frequently Asked Questions FAQs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_was_Sanofi_India_Q4_FY26_PAT\"><\/span><strong>What was Sanofi India Q4 FY26 PAT?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Sanofi India Q4 FY26 records PAT of Rs 92 crore, higher year-on-year. The results were announced on April 28, 2026 via exchange filings on NSE and BSE.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_Sanofi_India_revenue_in_Q4_FY26\"><\/span><strong>What was Sanofi India revenue in Q4 FY26?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Sanofi India Q4 FY26 records revenue of approximately Rs 720 crore (year-on-year growth). Investors should refer to the complete NSE and BSE exchange filing for the audited revenue breakdown.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_Sanofi_India_declare_a_dividend_for_FY26\"><\/span><strong>Did Sanofi India declare a dividend for FY26?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>As per available information, Sanofi India has not declared a dividend for FY26 in the Q4 results announcement. Refer to the official exchange filing for the latest update.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_did_Sanofi_India_perform_in_FY26_overall\"><\/span><strong>How did Sanofi India perform in FY26 overall?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>FY26 was a year of stable growth for Sanofi India, with the prescription pharma business benefiting from increasing diabetes and cardiovascular disease burden in India and growing physician and patient engagement programmes&#8230;. Investors can track the complete annual performance metrics in the company&#8217;s FY26 annual report and exchange filings.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_outlook_for_Sanofi_India_in_FY27\"><\/span><strong>What is the outlook for Sanofi India in FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Sanofi India FY27 growth will be driven by expanding access to its diabetes and specialty care portfolio. The global parent&#8217;s pipeline of specialty biologics, if approved for India, could significantly expand the India business in the medium term.. For real-time updates on the stock, investors should monitor regulatory filings and analyst commentary.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_track_Sanofi_India_stock_and_results\"><\/span><strong>Where can I track Sanofi India stock and results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Investors can track Sanofi India (NSE: SANOFI) share price, financial results, and analyst data on NSE India, BSE India, and financial platforms. The Q4 FY26 results were filed on April 28, 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_sector_does_Sanofi_India_operate_in\"><\/span><strong>What sector does Sanofi India operate in?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Sanofi India operates in the Pharmaceuticals sector in India. The company is listed on both NSE and BSE. Investors should review the company&#8217;s business model, competitive positioning, and risk factors before making any investment decision.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Sanofi_India_a_good_investment_after_Q4_FY26_results\"><\/span><strong>Is Sanofi India a good investment after Q4 FY26 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Whether Sanofi India is a good investment depends on your individual financial goals, risk tolerance, and investment horizon. The Q4 FY26 results provide one data point about the company&#8217;s performance. Please consult a SEBI registered financial advisor before making any investment decision.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Article\"><\/span><strong>Recent Article<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/vrl-logistics-q4-results-2026-2\">VRL Logistics Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/vraj-iron-and-steel-q4-results-2026\">Vraj Iron and Steel Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/voltas-q4-results-2026\">Voltas Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/voltamp-transformers-q4-results-2026\">Voltamp Transformers Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/vodafone-idea-q4-results-2026\">Vodafone Idea Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Sanofi India Q4 FY26 results: PAT Rs 92 crore, higher YoY. Key highlights, financial analysis, outlook and FAQs. April 2026.<\/p>\n","protected":false},"author":23,"featured_media":79347,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-79327","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1777449433:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["79"],"rank_math_focus_keyword":["Sanofi India Q4"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_title":["Sanofi India Q4 FY26 Results PAT Growth as Prescription Pharma Portfolio Delivers"],"rank_math_description":["Sanofi India Q4 FY26 results: PAT Rs 92 crore higher year-on-year, Key highlights, financial table, outlook and FAQs. April 2026."],"_thumbnail_id":["79347"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["9650"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/29130910\/Sanofi-India-Q4-FY26-Results.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/79327","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=79327"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/79327\/revisions"}],"predecessor-version":[{"id":79365,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/79327\/revisions\/79365"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/79347"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=79327"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=79327"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=79327"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}